ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 60 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $106,560 | -20.2% | 18,000 | 0.0% | 0.06% | -14.1% |
| Q2 2023 | $133,560 | -25.6% | 18,000 | -5.3% | 0.06% | -29.7% |
| Q1 2023 | $179,550 | -15.7% | 19,000 | -5.0% | 0.09% | -21.6% |
| Q4 2022 | $213,000 | +43.9% | 20,000 | 0.0% | 0.12% | +38.1% |
| Q3 2022 | $148,000 | +54.2% | 20,000 | 0.0% | 0.08% | +58.5% |
| Q2 2022 | $96,000 | – | 20,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corton Capital Inc. | 13,966 | $103,000 | 0.13% |
| Delphia (USA) Inc. | 14,226 | $105,000 | 0.12% |
| Sentinus, LLC | 22,500 | $166,000 | 0.10% |
| Intrepid Financial Planning Group LLC | 20,000 | $148,000 | 0.08% |
| PERRITT CAPITAL MANAGEMENT INC | 12,000 | $89,000 | 0.06% |
| J. Goldman & Co LP | 148,738 | $1,098,000 | 0.05% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 88,966 | $657,000 | 0.02% |
| EMFO, LLC | 1,666 | $12,000 | 0.01% |
| Virtu Financial LLC | 12,590 | $93,000 | 0.01% |
| Jump Financial, LLC | 23,400 | $173,000 | 0.01% |